Back to today’s briefing

Story perspectives

Mission Bio Launches Tapestri: A New Era in CRISPR

5/23/2025

38 8

Summary

Story summary

At the ASGCT 28th Annual Meeting in New Orleans, Brian Kim, CEO of Mission Bio, unveiled the groundbreaking Tapestri platform for single-cell sequencing. He emphasized the growing excitement around CRISPR therapies, sharing a compelling case study, while also pointing to a revival of adeno-associated virus (AAV) vector strategies. Mission Bio is eager to forge new partnerships in this evolving landscape.

1 of 1

Story summary

At the ASGCT 28th Annual Meeting in New Orleans, Brian Kim, CEO of Mission Bio, unveiled the groundbreaking Tapestri platform for single-cell sequencing. He emphasized the growing excitement around CRISPR therapies, sharing a compelling case study, while also pointing to a revival of adeno-associated virus (AAV) vector strategies. Mission Bio is eager to forge new partnerships in this evolving landscape.